Asthma and COPD Drugs Market
Asthma and COPD Drugs Market - Global Industry Assessment & Forecast
Segments Covered
- By Diseases Asthma, COPD
- By Medication Class Combination Drugs, Bronchodilators, Inhaled Corticosteroids (ICS), Short Acting Beta Agonists (SABA), Long Acting Beta Agonists (LABA), Leukotriene Antagonists (LTA), Anticholinergics, Anti-Inflammatories, Other Classes
- By Distribution Channel Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2023 |
Forecast Years: | 2024 - 2032 |
Historical Years: | 2018 - 2022 |
Revenue 2023: | USD 37.42 Billion |
Revenue 2032: | USD 57.56 Billion |
Revenue CAGR (2024 - 2032): | 4.9% |
Fastest Growing Region (2024 - 2032) | Europe |
Largest Region (2023): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Asthma and COPD Drugs Market Segment Analysis
- Asthma and COPD Drugs Diseases Outlook (Revenue, USD Million, 2018 - 2030)
- Asthma
- COPD
- Asthma and COPD Drugs Medication Class Outlook (Revenue, USD Million, 2018 - 2030)
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- Asthma and COPD Drugs Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
-
North America Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
-
North America Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- U.S.
- U.S. Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- U.S. Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- U.S. Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- U.S. Asthma and COPD Drugs Market, by Diseases
- Canada
- Canada Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- Canada Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- Canada Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Canada Asthma and COPD Drugs Market, by Diseases
-
Mexico
- Mexico Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- Mexico Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- Mexico Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Mexico Asthma and COPD Drugs Market, by Diseases
-
North America Asthma and COPD Drugs Market, by Diseases
- Europe
-
Europe Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
-
Europe Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
-
Europe Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- U. K.
- U.K. Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- U.K. Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- U.K. Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- U.K. Asthma and COPD Drugs Market, by Diseases
- France
- France Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- France Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- France Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- France Asthma and COPD Drugs Market, by Diseases
-
Germany
- Germany Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- Germany Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- Germany Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Germany Asthma and COPD Drugs Market, by Diseases
-
Italy
- Italy Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- Italy Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- Italy Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Italy Asthma and COPD Drugs Market, by Diseases
-
Spain
- Spain Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- Spain Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- Spain Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Spain Asthma and COPD Drugs Market, by Diseases
-
Rest of Europe
- Rest of Europe Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- Rest of Europe Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- Rest of Europe Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Rest of Europe Asthma and COPD Drugs Market, by Diseases
-
Europe Asthma and COPD Drugs Market, by Diseases
- Asia Pacific
-
Asia Pacific Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
-
Asia Pacific Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
-
Asia Pacific Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- China
- China Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- China Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- China Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- China Asthma and COPD Drugs Market, by Diseases
- Japan
- Japan Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- Japan Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- Japan Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Japan Asthma and COPD Drugs Market, by Diseases
-
Germany
- Germany Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- Germany Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- Germany Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Germany Asthma and COPD Drugs Market, by Diseases
-
India
- India Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- India Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- India Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- India Asthma and COPD Drugs Market, by Diseases
-
South Korea
- South Korea Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- South Korea Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- South Korea Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- South Korea Asthma and COPD Drugs Market, by Diseases
-
South East Asia
- South East Asia Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- South East Asia Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- South East Asia Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- South East Asia Asthma and COPD Drugs Market, by Diseases
-
Rest of Asia Pacific
- Rest of Asia Pacific Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- Rest of Asia Pacific Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- Rest of Asia Pacific Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Rest of Asia Pacific Asthma and COPD Drugs Market, by Diseases
-
Asia Pacific Asthma and COPD Drugs Market, by Diseases
- Latin America
-
Latin America Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
-
Latin America Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
-
Latin America Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Brazil
- Brazil Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- Brazil Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- Brazil Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Brazil Asthma and COPD Drugs Market, by Diseases
- Argentina
- Argentina Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- Argentina Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- Argentina Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Argentina Asthma and COPD Drugs Market, by Diseases
-
Rest of Latin America
- Rest of Latin America Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- Rest of Latin America Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- Rest of Latin America Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Rest of Latin America Asthma and COPD Drugs Market, by Diseases
-
Latin America Asthma and COPD Drugs Market, by Diseases
- Middle East & Africa
-
Middle East & Africa Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
-
Middle East & Africa Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
-
Middle East & Africa Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- GCC Countries
- GCC Countries Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- GCC Countries Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- GCC Countries Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- GCC Countries Asthma and COPD Drugs Market, by Diseases
- South Africa
- South Africa Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- South Africa Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- South Africa Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- South Africa Asthma and COPD Drugs Market, by Diseases
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Asthma and COPD Drugs Market, by Diseases
- Asthma
- COPD
- Rest of Middle East & Africa Asthma and COPD Drugs Market, by Medication Class
- Combination Drugs
- Bronchodilators
- Inhaled Corticosteroids (ICS)
- Short Acting Beta Agonists (SABA)
- Long Acting Beta Agonists (LABA)
- Leukotriene Antagonists (LTA)
- Anticholinergics
- Anti-Inflammatories
- Other Classes
- Rest of Middle East & Africa Asthma and COPD Drugs Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Rest of Middle East & Africa Asthma and COPD Drugs Market, by Diseases
-
Middle East & Africa Asthma and COPD Drugs Market, by Diseases
- North America
FAQ
Frequently Asked Question
What is the global demand for Asthma and COPD Drugs in terms of revenue?
-
The global Asthma and COPD Drugs valued at USD 37.42 Billion in 2023 and is expected to reach USD 57.56 Billion in 2032 growing at a CAGR of 4.9%.
Which are the prominent players in the market?
-
The prominent players in the market are Novartis AG (Switzerland), Cipla Inc. (India), Abbott Laboratories (U.S.), Astellas Pharma (Japan), Hoffmann-La Roche Ltd. (Switzerland), Glenmark Pharmaceuticals (India), Verona Pharma PLC (UK), AstraZeneca (UK), GSK (UK), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co. Inc. (U.S.), Grifols S.A. (Spain).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 4.9% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Asthma and COPD Drugs include
- The rising incidence of asthma and COPD globally is a significant driver for the market, primarily fueled by several interconnected factors
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Asthma and COPD Drugs in 2023.